Professional Documents
Culture Documents
Cepheid Xpert Xpress CoV 2 Plus Comparison EUA 0923 English HIR
Cepheid Xpert Xpress CoV 2 Plus Comparison EUA 0923 English HIR
In order to help in your transition from Xpert Xpress SARS-CoV-2 and/or Xpert Xpress SARS-CoV-2/Flu/RSV to
Xpert Xpress CoV-2 plus to Xpert Xpress CoV-2/Flu/RSV plus, we would like to highlight the differences in the
product configurations and attributes. This is a quick reference guide. Complete test resources can be found online:
cepheid.com/coronavirus-product-resources.
N2 gene N2 gene
N2 gene
SARS CoV-2 Gene Targets E gene E gene
E gene
RdRP gene RdRP gene
Positive
Positive Positive
Presumptive Positive
Possible Reported Results Negative Negative
Negative
Invalid Invalid
Invalid
1
Xpert® Xpress
Respiratory Product Comparison — EUA
ZeptoMetrix Positive
ZeptoMetrix NATtrol Flu/
and Negative Control
RSV/SARS-CoV-2 Positive SeraCare AccuPlex Reference
Supported External and Negative Control kits,
kits, #NATSARS(COV2)-
Material Kit, catalog number
Controls ERC (Positive) and
#NATFRC-6C (Positive) and 0505-0126
#NATSARS(COV2)-NEG
#NATCV9-6C (Negative)
(Negative)
These tests have not been FDA cleared or approved. These tests have been authorized by FDA under an EUA for use by authorized laboratories. Xpert Xpress SARS-CoV-2
and Xpert Xpress CoV-2 plus have been authorized only for the detection of nucleic acids from SARS-CoV-2, and not for any other viruses or pathogens. Xpert Xpress
CoV-2/Flu/RSV plus has been authorized only for the simultaneous qualitative detection and differentiation of nucleic acids from SARS-CoV-2, influenza A, influenza B,
and respiratory syncytial virus (RSV), and not for any other viruses or pathogens. These tests are only authorized for the duration of the declaration that circumstances
exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. §
360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.
1 Specimen type not supported for use with GeneXpert Xpress systems (point of care)
2 For use with only Anterior Nasal Swabs or Nasopharyngeal Swabs
3 With Early Assay Termination (EAT)
4 If an ADF CD is required, please make a request by filling out a form at https://www.cepheid.com/en/contact/request-cd-international
5 Please visit cepheid.com/coronavirus
6 Claimed LOD is determined by the weakest of the three targets